Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy

Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses

Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia

Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia

Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts

Dendritic cell-based immunotherapy for the treatment of hematological malignancies

Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro

A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia